Hormonal
GLP-1 receptor agonists (GLP-1RAs) such as liraglutide and exenatide effectively treat Type 2 Diabetes by enhancing insulin secretion and inducing weight loss, serving as a pharmacological alternative to bariatric surgery.
If you have Type 2 Diabetes and struggle with weight, GLP-1 medications like liraglutide or exenatide are proven to help your body produce more insulin and lose weight. They are a viable alternative to bariatric surgery, offering similar benefits without the surgical risks. Consult your doctor to see if this class of medication is appropriate for you.
GLP-1 analogues (eg liraglutide and exenatide) are used to treat T2D as they promote insulin secretion and induce weight loss. Since the GLP-1 receptor (GLP-1R) agonists are effective in treating diabesity, they could be pharmacological alternatives to bariatric surgery but without the post-surgery complications.
Why this rating
Based on a comprehensive review of current trends and established clinical efficacy, though specific trial data is summarized rather than presented as primary research.
Source
A Review of Current Trends with Type 2 Diabetes Epidemiology, Aetiology, Pathogenesis, Treatments and Future Perspectives
Josh Reed et al. · Diabetes Metabolic Syndrome and Obesity · 2021
DOI 10.2147/dmso.s319895
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →